U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H20N2O2.C14H21ClN2O2
Molecular Weight 593.156
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOFEZONE ANHYDROUS

SMILES

CCN(CC)CCNC(=O)COC1=CC=C(Cl)C=C1.CCCCC2C(=O)N(N(C2=O)C3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=ICBCZMIEENEERJ-UHFFFAOYSA-N
InChI=1S/C19H20N2O2.C14H21ClN2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16;1-3-17(4-2)10-9-16-14(18)11-19-13-7-5-12(15)6-8-13/h4-13,17H,2-3,14H2,1H3;5-8H,3-4,9-11H2,1-2H3,(H,16,18)

HIDE SMILES / InChI

Molecular Formula C14H21ClN2O2
Molecular Weight 284.782
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C19H20N2O2
Molecular Weight 308.3743
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Clofezone (Perclusone), an analgesic and anti-inflammatory agent, is a drug that was used to treat joint and muscular pain, mostly in rheumatic diseases. Clofezone is a compound preparation of phenylbutazone and clofexamide. Tolerance of Perclusone was very good, no side-effects were observed.

Approval Year

PubMed

PubMed

TitleDatePubMed
[Clinical trial of a new anti-inflammatory agent in rheumatology, ANP 3260 or clofezone].
1968 Mar
Patents

Sample Use Guides

In Vivo Use Guide
The effectiveness and acceptability of clofezone (Perclusone) were compared with those of diclofenac in a placebo-controlled, double-blind, cross-over trial on a group of 29 out-patients suffering from osteoarthrosis of the knee or hip. Clofezone was given at a daily dosage of 1200 mg during the first week and 600 mg during the second week; the corresponding dosages of diclofenac were 150 mg and 75 mg.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:45:01 UTC 2023
Edited
by admin
on Fri Dec 15 18:45:01 UTC 2023
Record UNII
5RB28NE79Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLOFEZONE ANHYDROUS
Common Name English
3,5-PYRAZOLIDINEDIONE, 4-BUTYL-1,2-DIPHENYL-, COMPD. WITH 2-(4-CHLOROPHENOXY)-N-(2-(DIETHYLAMINO)ETHYL)ACETAMIDE (1:1)
Systematic Name English
ACETAMIDE, 2-(4-CHLOROPHENOXY)-N-(2-(DIETHYLAMINO)ETHYL)-, COMPD. WITH 4-BUTYL-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE (1:1)
Systematic Name English
CLOFEXAMIDE-PHENYLBUTAZONE
Common Name English
Classification Tree Code System Code
WHO-ATC M01AA05
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
WHO-ATC M02AA03
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
Code System Code Type Description
ECHA (EC/EINECS)
241-466-7
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
PRIMARY
NCI_THESAURUS
C171850
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
PRIMARY
SMS_ID
100000084314
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
PRIMARY
EPA CompTox
DTXSID30169831
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
PRIMARY
EVMPD
SUB06705MIG
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
PRIMARY
CAS
17449-96-6
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
PRIMARY
FDA UNII
5RB28NE79Y
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
PRIMARY
PUBCHEM
6433695
Created by admin on Fri Dec 15 18:45:01 UTC 2023 , Edited by admin on Fri Dec 15 18:45:01 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
SOLVATE->ANHYDROUS